Inventor
SHIBUYA AKITO
JP13 patents
⚠️ This page may combine multiple inventors who share the name “SHIBUYA AKITO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
6 patentsUS10980825B2Apr 20, 2021
Cyclic dinucleotide
TAKEDA PHARMACEUTICALS CO6 citations82
US9890145B2Feb 13, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO8 citations82
US11186565B2Nov 30, 2021
Aromatic compound
TAKEDA PHARMACEUTICALS CO3 citations71
US11666594B2Jun 6, 2023
Antibody-drug conjugates comprising a cyclic dinucleotide
TAKEDA PHARMACEUTICALS CO2 citations70
US9776962B2Oct 3, 2017
Aromatic compounds with GPR40 agonistic activity
TAKEDA PHARMACEUTICALS CO2 citations70
US12171777B2Dec 24, 2024
Methods of making a cyclic dinucleotide
TAKEDA PHARMACEUTICALS CO0 citations60
CARDURION PHARMACEUTICALS LLC
3 patentsUS10543212B2Jan 28, 2020
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC10 citations80
US11197858B2Dec 14, 2021
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC0 citations59
US11130752B2Sep 28, 2021
Aminopyrimidine compound
CARDURION PHARMACEUTICALS LLC0 citations49
TAKEDA PHARMACEUTICAL
2 patentsCARDURION PHARMACEUTICALS INC
2 patentsUS12528816B2Jan 20, 2026
Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitors
CARDURION PHARMACEUTICALS INC0 citations59
US11795172B2Oct 24, 2023
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors
CARDURION PHARMACEUTICALS INC0 citations59